| abstract |
(57) [Summary] The present invention provides a compound of formula (I): (Wherein R 1 to R 7 have the same meaning as in the specification), and thus has a binding inhibitory activity between VCAM-1 and VLA-4 expressing cells. Relates to compounds that are useful in the treatment of diseases such as chronic inflammatory diseases having symptoms and disorders associated with -1 binding. |